Cargando…

Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer

Although immunotherapy has revolutionized cancer treatment and achieved remarkable success across many different cancer types, only a subset of patients shows meaningful clinical responses. In particular, advanced prostate cancer exhibits overwhelming de novo resistance to immune checkpoint blockade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yini, Duong, Loan, Lu, Xuemin, Lu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069702/ https://www.ncbi.nlm.nih.gov/pubmed/36367020 http://dx.doi.org/10.4103/aja202283

Ejemplares similares

Molecular signaling involving intrinsically disordered proteins in prostate cancer
por: Russo, Anna, et al.
Publicado: (2016)

Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins
por: Mooney, Steven M, et al.
Publicado: (2016)

Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer
por: Kulkarni, Prakash, et al.
Publicado: (2016)

Unfoldomics of prostate cancer: on the abundance and roles of intrinsically disordered proteins in prostate cancer
por: Landau, Kevin S, et al.
Publicado: (2016)

Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms
por: Huang, Yu-Hua, et al.
Publicado: (2019)

Intrinsically disordered proteins and prostate cancer: pouring new wine in an old bottle
por: Kulkarni, Prakash
Publicado: (2016)

Circadian rhythm in prostate cancer: time to take notice of the clock
por: Zhu, Wei-Zhen, et al.
Publicado: (2022)

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
por: Choi, Stephen Yiu Chuen, et al.
Publicado: (2013)

Prostate cancer stem cells
por: Lang, SH, et al.
Publicado: (2009)

Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer
por: Wong, Nelson K. Y., et al.
Publicado: (2022)

Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019)

Role of chemotherapy in prostate cancer
por: Nader, Rita, et al.
Publicado: (2018)

Vitamin D in prostate cancer
por: Trump, Donald L, et al.
Publicado: (2018)

Prostate cancer in East Asia: evolving trend over the last decade
por: Zhu, Yao, et al.
Publicado: (2015)

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
por: Gourdin, Theodore, et al.
Publicado: (2018)

Glucocorticoids and prostate cancer treatment: friend or foe?
por: Montgomery, Bruce, et al.
Publicado: (2014)

The role of mRNA splicing in prostate cancer
por: Lapuk, Anna V, et al.
Publicado: (2014)

Current early diagnostic biomarkers of prostate cancer
por: Qu, Min, et al.
Publicado: (2014)

Clinical variability and molecular heterogeneity in prostate cancer
por: Shoag, Jonathan, et al.
Publicado: (2016)

Prostate cancer epigenetics and its clinical implications
por: Yegnasubramanian, Srinivasan
Publicado: (2016)

Perspectives on the clinical development of immunotherapy in prostate cancer
por: Cordes, Lisa M, et al.
Publicado: (2018)

The regulatory pathways leading to stem-like cells underlie prostate cancer progression
por: Lin, Chun-Jung, et al.
Publicado: (2019)

Multiple therapeutic and preventive effects of 3,3′-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
por: Zhang, William Weiben, et al.
Publicado: (2014)

SATB1-mediated chromatin landscape in T cells
por: Zelenka, Tomas, et al.
Publicado: (2020)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Anti-angiogenesis in prostate cancer: knocked down but not out
por: Bilusic, Marijo, et al.
Publicado: (2014)

New developments in the treatment of castration resistant prostate cancer
por: Wadia, Roxanne, et al.
Publicado: (2014)

Genomic predictors for treatment of late stage prostate cancer
por: Shevrin, Daniel H
Publicado: (2016)

Lineage plasticity-mediated therapy resistance in prostate cancer
por: Blee, Alexandra M, et al.
Publicado: (2019)

Epigenetic regulation of prostate cancer: the theories and the clinical implications
por: Liao, Yiji, et al.
Publicado: (2019)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

Extrinsic and intrinsic factors controlling spermatogonial stem cell self-renewal and differentiation
por: Mei, Xing-Xing, et al.
Publicado: (2015)

Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
por: Feng, Ninghan, et al.
Publicado: (2019)

Chemotherapy and its evolving role in the management of advanced prostate cancer
por: Schweizer, Michael T, et al.
Publicado: (2014)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Hormone naïve prostate cancer: predicting and maximizing response intervals
por: Moul, Judd W
Publicado: (2015)

Multiparametric ultrasound in the detection of prostate cancer: a systematic review
por: Postema, Arnoud, et al.
Publicado: (2015)

Clinical validity and utility of genetic risk scores in prostate cancer
por: Helfand, Brian T, et al.
Publicado: (2016)

Long noncoding RNAs in prostate cancer: overview and clinical implications
por: Malik, Bhavna, et al.
Publicado: (2016)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fmeq06eorqnpu82m54cpce8juk